ArticleBMJ oncology2024

Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial.

Matthew Tucker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.